Ikena Oncology (IKNA) Financials

$1.43

$-15.01 (-91.30%)

As on 25-Jul-2025 16:21EDT

Market cap

$719 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	9.16	15.62	30.99	9.19
Cost of Revenue	0.18	0.49	1.02	64.32	47.11	44.85
Gross Profit	0.05	-0.49	8.14	13.58	-16.12	-35.65
Operating Expenses	44.47	54.06	83.56	84.49	18.02	8.87
Operating Profit (EBIT)	-44.16	-58.97	-75.42	-70.90	-34.14	-44.52
Other Income	--	--	--	2.15	0.02	--
Profit before Tax	-30.64	-49.08	-68.33	-68.77	-34.12	-44.26
Provision for Tax	0.02	0.15	-0.16	-2.14	0.31	0.09
Profit after Tax (Net Income)	-30.74	-49.23	-68.17	-68.77	-34.12	-44.26
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-68.77	-34.12	-44.26

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	115.91	125.93	169.76	146.97	207.88	-101.05
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.94	4.80	8.13	3.79	12.81	241.12
Current Liabilities	7.32	10.78	14.21	21.50	27.19	28.33
Total Liabilities	133.49	141.51	192.09	172.26	247.88	168.40

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	27.15	14.34	13.43	12.25	11.36	2.44
Current Assets	99.01	127.17	178.66	160.01	236.52	165.97
Total Assets	133.49	141.51	192.09	172.26	247.88	168.40
Total Debt*	5.68	7.52	10.74	5.69	6.99	0.19
Net Current Assets	91.69	116.39	164.46	138.51	209.33	137.64

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-46.00	-79.74	-74.11	-60.25	-37.83
Cash Flow from Investing Activities	--	-34.90	64.14	-99.28	-1.76	2.92
Cash from Financing Activities	--	--	75.98	1.10	131.74	116.18
Net Cash Inflow / Outflow	--	--	--	-172.30	69.73	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.64	-1.02	-1.43	-1.90	-0.95	-3.16
Cash EPS ($)	--	-1.01	-1.41	-1.88	-0.94	-3.14
Adjusted Book Value ($)	--	2.61	3.55	4.05	5.80	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.95	-1.67	-2.04	-1.68	-2.70
Free Cash Flow per Share ($)	--	-0.95	-1.68	-2.08	-1.73	-2.76

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-31.36	-40.92	-37.42	-59.85	1,927.95
ROE (%)	-25.42	-33.30	-43.04	-38.76	-63.87	105.82
ROA (%)	-20.55	-29.52	-37.42	-32.73	-16.39	-34.80
EBIT Margin (%)	--	--	-823.33	-453.99	-110.18	-484.22
Net Margin (%)	--	--	-744.17	-387.04	-110.02	-481.36
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	-1.00	-0.41	-0.50	2.37	-0.33
EBIT Growth (%)	41.87	34.92	-6.36	-107.70	23.32	-142.33
Net Profit Growth (%)	53.91	27.77	0.87	-101.57	22.91	-163.16
EPS Growth (%)	55.32	0.28	0.25	-0.99	0.70	0.50
Book Value Growth (%)	-18.87	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.61	-1.38	-1.40	-13.18	--
Price / Book Value	6.20	0.63	0.55	0.66	2.16	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.54	0.78	0.95	0.78	-6.68	--
Close Price ($)	16.08	19.68	23.64	31.92	150.48	--
High Price ($)	23.28	24.84	91.68	172.14	451.32	--
Low Price ($)	11.65	14.64	12.24	23.28	115.56	--
Market Cap ($ Cr)	718.82	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.06	0.06	0.04	0.03	0.00
Short term debt to equity ratio	0.03	0.06	0.02	0.01	0.02	0.00
Current Ratio	13.52	11.80	12.58	7.44	8.70	5.86
Quick Ratio	13.52	--	--	--	--	--
Interest Coverage	--	--	--	-32.99	-1,484.26	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	0.05	0.07	0.15	0.07
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	1,104.32	744.64	12.71	17.47	12.45
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.